Jay Shepard
Director/Board Member at ESPERION THERAPEUTICS, INC.
Net worth: 996 588 $ as of 30/06/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Pearson | M | 57 |
Cessation Therapeutics, LLC
 Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Cessation Therapeutics, LLC is a clinical-stage pharmaceutical company that develops immunobiologics to prevent and protect against overdose. The company is based in San Jose, CA. The company's monoclonal antibodies are designed to target fentanyl and future synthetic opioids and other substances. The company has the potential to treat a range of substance use disorders and improve the lives of patients and families affected by the addiction crisis. Cessation was founded in 2018 by Mark Pearson and John D. Harkey, Jr., experienced, successful long-term biotech investors. The CEO is Mark E. Pearson.
Altamont Pharma Acquisition Corp.
 Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Altamont Pharma Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 6, 2021 and is headquartered in Austin, TX. | - |
| Tracy Woody | F | 54 |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | 7 years |
| Thomas McCourt | M | 66 | 15 years | |
| Jacqueline Shea | M | 58 | 5 years | |
| David G. Genecov | M | - |
Cessation Therapeutics, LLC
Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Cessation Therapeutics, LLC is a clinical-stage pharmaceutical company that develops immunobiologics to prevent and protect against overdose. The company is based in San Jose, CA. The company's monoclonal antibodies are designed to target fentanyl and future synthetic opioids and other substances. The company has the potential to treat a range of substance use disorders and improve the lives of patients and families affected by the addiction crisis. Cessation was founded in 2018 by Mark Pearson and John D. Harkey, Jr., experienced, successful long-term biotech investors. The CEO is Mark E. Pearson. | - |
| Sheldon Koenig | M | 58 | 4 years | |
| Jandell T. Allen-Davis | M | - |
Craig Hospital
 Craig Hospital Hospital/Nursing ManagementHealth Services Craig Hospital is a center for specialty rehabilitation and research for people with spinal cord injury and traumatic brain injury. The firm provides a system of inpatient and outpatient medical care, rehabilitation, neurosurgical rehabilitative care and long-term follow up services. The company was founded in 1907 and is headquartered in Denver, CO. | 6 years |
| Ashwin Ram | M | - |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands.
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | - |
| Julie McHugh | F | 59 | 10 years | |
| Neal Fowler | M | 62 |
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler.
Catalys Pacific LLC
Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | - |
| Robert Finocchio | M | 72 |
Santa Clara University
| 24 years |
| Simon Benito | M | 79 | 21 years | |
| BT Slingsby | M | 47 |
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | - |
| Marianne Andreach | F | - | - | |
| Benjamin Halladay | M | 38 | 4 years | |
| Michelle Barsanti | F | - |
Santa Clara University
| - |
| Marcel Moulaison | M | - | 10 years | |
| Catherine Moukheibir | F | 64 | 5 years | |
| Mike Nanfito | M | - | 12 years | |
| David Weiner | M | 67 | 41 years | |
| Thomas E. Balazy | M | - |
Craig Hospital
Craig Hospital Hospital/Nursing ManagementHealth Services Craig Hospital is a center for specialty rehabilitation and research for people with spinal cord injury and traumatic brain injury. The firm provides a system of inpatient and outpatient medical care, rehabilitation, neurosurgical rehabilitative care and long-term follow up services. The company was founded in 1907 and is headquartered in Denver, CO. | 37 years |
| Krishnan Mahesh /davita/ | - | - |
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | - |
| Michael Hindery | M | - |
Santa Clara University
| 10 years |
| Marla Kessler | F | 54 | 5 years | |
| John Minardo | M | 49 | 3 years | |
| Lisa Walters-Hoffert | F | 65 |
Altamont Pharma Acquisition Corp.
Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Altamont Pharma Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 6, 2021 and is headquartered in Austin, TX. | - |
| Roger Dansey | M | 67 | 3 years | |
| Ronald Silver | M | 42 | 6 years | |
| Benjamin Looker | M | 42 | 2 years | |
| Ann Miller | M | 66 | 5 years | |
| Jon Duane | M | 65 | 5 years | |
| Andrew Dreyfus | M | 65 | 8 years | |
| Radha Basu | F | 73 |
Santa Clara University
| 14 years |
| Stephen Rocamboli | M | 52 | 2 years | |
| Wendy Yarno | F | 68 | 7 years | |
| Byron Scordelis | M | 74 |
Santa Clara University
| - |
| Antonio Gotto | M | 88 | 10 years | |
| Nicole Vitullo | F | 66 | 16 years | |
| Alan Fuhrman | M | 67 | 4 years | |
| Eric Warren | M | 76 | 3 years | |
| Mark Currie | M | 69 | 5 years | |
| J. Carroll | M | 74 | 2 years | |
| Lota Zoth | F | 64 | 6 years | |
| Alexander Denner | M | 54 | 4 years | |
| Cathy Oleson | F | - |
Santa Clara University
| - |
| Kevin Moul | M | - |
Santa Clara University
| - |
| Maria Constantino-Roelandts | F | - |
Santa Clara University
| - |
| Angelo Danna | M | - |
Santa Clara University
| - |
| Nicholas Farros | M | - |
Santa Clara University
| - |
| Susan Gaddis | F | - |
Santa Clara University
| - |
| Thomas Glascott | M | - |
Santa Clara University
| - |
| Jonathan Varni | M | - |
Santa Clara University
| - |
| Peter J. M. Dalton | M | 80 |
Santa Clara University
| - |
| John M. Grillos | M | - |
Santa Clara University
| - |
| Rebecca Schapp | F | - |
Santa Clara University
| - |
| Lawrence Biggam | M | - |
Santa Clara University
| - |
| Donald Lightbody | M | - |
Santa Clara University
| - |
| Victor LoBue | M | - |
Santa Clara University
| - |
| Louis Mariani | M | - |
Santa Clara University
| - |
| David Le Baron | M | - |
Santa Clara University
| - |
| Anne Milligan | F | - |
Santa Clara University
| - |
| Arthur Liebscher | M | - |
Santa Clara University
| - |
| Angela Polk | F | - |
Santa Clara University
| - |
| Christine O'Malley | F | - |
Santa Clara University
| - |
| Dolores Murphy | F | - |
Santa Clara University
| - |
| Bill Coleman | M | 75 |
Santa Clara University
| - |
| Amy Williams Bick | F | - |
Santa Clara University
| - |
| Robert Howard Smith | M | 88 |
Santa Clara University
| - |
| Martin R. Melone | M | 82 |
Santa Clara University
| - |
| Diane Stroehmann | F | 46 | 5 years | |
| Daniel K. O'Neill | M | 62 |
Santa Clara University
| - |
| Stephen Johnson | M | - |
Santa Clara University
| - |
| Philip McGarrigle | M | - |
Santa Clara University
| 24 years |
| Kirk O. Hanson | M | - |
Santa Clara University
| - |
| Patrick Yam | M | - |
Santa Clara University
| 27 years |
| Chaiho Kim | M | 89 |
Santa Clara University
| 60 years |
| Beth Calitri | F | - | 5 years | |
| David C. Drummond | M | 60 |
Santa Clara University
| 19 years |
| Lewis N. Wolff | M | 87 |
Santa Clara University
| - |
| Tim Haley | M | 69 |
Santa Clara University
| - |
| Daniel Bane | M | 76 |
Santa Clara University
| - |
| John E. Kerrigan | M | 69 |
Santa Clara University
| 22 years |
| Thaddeus John Whalen | M | 88 |
Santa Clara University
| 62 years |
| Lisa Stevens | F | - |
Santa Clara University
| - |
| Kenton D. Chow | M | - |
Santa Clara University
| - |
| Michael Shetzline | M | 65 | 5 years | |
| P. Anthony Ridder | M | 83 |
Santa Clara University
| - |
| Timothy David Harris | M | 69 |
Santa Clara University
| - |
| Robert Moles | M | 69 |
Santa Clara University
| - |
| Carl E. Thoresen | M | - |
Santa Clara University
| - |
| Dale D. Achabal | M | 78 |
Santa Clara University
| - |
| Greg Martini | M | - | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Srini Akkaraju Akkaraju | M | 56 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | 3 years |
| Gail McIntyre | M | 61 | 6 years | |
| Mike Burdick | M | - |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | 4 years |
| Gina Consylman | F | 52 | 7 years | |
| Tim Mayleben | M | 63 | 11 years | |
| J. Kim | M | 55 | 13 years | |
| Rekha Hemrajani | F | 54 | - | |
| Jason Rickard | M | 53 | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
| Japan | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jay Shepard
- Personal Network
